Karuna Therapeutics Inc (NASDAQ:KRTX)
| 173.48 BATS BZX Real-Time Price As of 1:30pm ET |  +12.27 / +7.61%Today’s Change | 92.26 Today|||52-Week Range 278.25 | -11.72% Year-to-Date |
Institutional investors purchased a net $1.6 million shares of KRTX during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 88.31% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Major industry average.
| Mutual fund holders | 54.05% |
| Other institutional | 34.26% |
| Individual stakeholders | 30.87% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 12/31/2022 | FIDELITY MANAGEMENT & RESEARCH C... Bought 647.2 Thousand shares of Karuna Therapeutics Inc |
| 12/31/2022 | BLACKROCK FUND ADVISORS Bought 360.9 Thousand shares of Karuna Therapeutics Inc |
| 12/31/2022 | T. ROWE PRICE INVESTMENT MANAGEM... Bought 229.4 Thousand shares of Karuna Therapeutics Inc |
Top 10 Owners of Karuna Therapeutics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Fidelity Management & Research Co... | 14.78% | 5,077,496 | 1,012,554,252 | +647,211 | +14.61% |
| The Vanguard Group, Inc. | 7.78% | 2,674,453 | 533,339,417 | +128,188 | +5.03% |
| T. Rowe Price Associates, Inc. (I... | 6.88% | 2,363,304 | 471,290,084 | +147,158 | +6.64% |
| BlackRock Fund Advisors | 5.72% | 1,966,428 | 392,145,072 | +360,883 | +22.48% |
| Capital Research & Management Co.... | 4.93% | 1,695,579 | 338,132,364 | 0 | 0.00% |
| T. Rowe Price Investment Manageme... | 3.50% | 1,202,631 | 239,828,674 | +229,374 | +23.57% |
| Viking Global Investors LP | 3.45% | 1,183,736 | 236,060,633 | +169,620 | +16.73% |
| Wellington Management Co. LLP | 3.07% | 1,055,076 | 210,403,256 | +53,973 | +5.39% |
| SSgA Funds Management, Inc. | 2.84% | 975,677 | 194,569,507 | +98,832 | +11.27% |
| AllianceBernstein LP | 1.70% | 583,382 | 116,338,038 | +57,892 | +11.02% |
Top 10 Mutual Funds Holding Karuna Therapeutics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Fidelity Growth Company Fund | 3.51% | 1,205,439 | 240,388,645 | -8,869 | -0.73% |
| American Funds Growth Fund of Ame... | 2.53% | 867,753 | 173,047,303 | 0 | 0.00% |
| Vanguard Total Stock Market Index... | 2.46% | 845,935 | 168,696,358 | +4,769 | +0.57% |
| Vanguard Small Cap Index Fund | 2.09% | 716,502 | 142,884,829 | +4,347 | +0.61% |
| iShares Russell 2000 ETF | 1.93% | 662,400 | 132,095,808 | -2,088 | -0.31% |
| T Rowe Price New Horizons Fund | 1.87% | 644,063 | 128,439,043 | +236,430 | +58.00% |
| T Rowe Price Health Sciences Fund | 1.75% | 601,875 | 120,025,913 | +2,518 | +0.42% |
| Eventide Healthcare & Life Scienc... | 1.51% | 519,700 | 103,638,574 | 0 | 0.00% |
| Vanguard Health Care Fund | 1.50% | 514,899 | 102,681,159 | 0 | 0.00% |
| Vanguard Small Cap Value Index Fu... | 1.47% | 505,655 | 100,837,720 | +4,504 | +0.90% |